Search

everythinglearnresearchcommunity

for

Search:↓

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document concludes that various clinical methods are used to assess ageing skin and the effectiveness of anti-ageing products.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

TNF-alpha inhibitors can cause various immune-related skin issues.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Changes in KRT17 gene activity linked to wool production in Angora rabbits.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Artemis dysfunction might cause hair loss through telomere shortening.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

TLR2 is important for hair growth and can be targeted to treat hair loss.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

The gel with CBD and EPA reduced wrinkles, improved skin hydration and elasticity, and had strong anti-aging effects.